At a glance
ClinicalIndex Comparison RecordN/ACompleted· 241 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VFEND SPECIAL INVESTIGATION FOR PROPHYLAXIS
In Brief
An observational study for Fungal Infection. Completed, enrolled 241 participants.
Detailed Summary
Examine the safety and effectiveness of Vfend \[voriconazole\] for prophylaxix use under general clinical practices.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFungal Infection
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2016
Enrollment StartMar 2016
Primary CompletionJul 2019
TodayJul 2026
First PostedFeb 4, 2016
Enrollment StartMar 11, 2016
Primary CompletionJul 3, 2019
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 10.4 years ago